MARKET

JYNT

JYNT

The Joint
NASDAQ

Real-time Quotes | Nasdaq Last Sale

106.17
-0.53
-0.50%
After Hours: 103.90 -2.27 -2.14% 17:24 09/17 EDT
OPEN
108.17
PREV CLOSE
106.70
HIGH
108.17
LOW
104.59
VOLUME
380.06K
TURNOVER
--
52 WEEK HIGH
111.06
52 WEEK LOW
16.03
MARKET CAP
1.53B
P/E (TTM)
91.12
1D
5D
1M
3M
1Y
5Y
Joint Insider Sold Over $2.02 Million In Company Stock
Ronald Davella V, Director at Joint (NASDAQ:JYNT), made a large insider sell on September 13, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that V sold 20,000 shares of Joint...
Benzinga · 1d ago
Insider Sell: Joint
MT Newswires · 1d ago
Why Should You Hold Centene (CNC) in Your Portfolio Now?
Zacks.com · 2d ago
Humana (HUM), Curant Health Team Up to Aid Chronic Patients
Zacks.com · 09/09 17:41
Encompass Health (EHC) Opens Hospital, Boosts Florida Footprint
Zacks.com · 09/02 13:17
Here's Why You Should Hold Molina Healthcare (MOH) Stock Now
Zacks.com · 09/02 04:00
CNBC PRO Talks: Star small-cap manager Amy Zhang unveils her top stock picks
Amy Zhang, portfolio manager of the Alger Small Cap Focus, Small Cap Growth and Mid Cap Focus strategies and Mid Cap 40 ETF, joins CNBC's Brian Sullivan to discuss the state of the small and mid-cap market, and the rationale for some of her top picks.
CNBC.com · 09/01 19:49
The Joint Chiropractic Emphasizes Posture, Backpack Weight & 'Tech Neck' as Kids Head Back to School
/PRNewswire/ -- The upcoming school year is going to be an adjustment for a lot of families. Between the transition back to in-person learning, organized sports, play dates and more, it can be taxing on young bodies. The Joint Corp. (NASDAQ: JYNT), the nat...
PR Newswire - PRF · 09/01 14:43
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of JYNT. Analyze the recent business situations of The Joint through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average JYNT stock price target is 124.60 with a high estimate of 150.00 and a low estimate of 105.00.
EPS
Institutional Holdings
Institutions: 197
Institutional Holdings: 14.00M
% Owned: 97.36%
Shares Outstanding: 14.38M
TypeInstitutionsShares
Increased
35
3.73M
New
63
615.40K
Decreased
53
2.87M
Sold Out
12
204.41K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+0.60%
Healthcare Providers & Services
+0.93%
Key Executives
President/Chief Executive Officer/Director
Peter Holt
Chief Financial Officer
Jake Singleton
Lead Director/Independent Director
Matthew Rubel
Independent Director
James Amos
Independent Director
Ronald DaVella
Independent Director
Suzanne Decker
Independent Director
Abe Hong
Independent Director
Glenn Krevlin
No Data
About JYNT
The Joint Corp develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. In addition to its operating clinics, the Company has granted franchises either directly or through its regional developers. The Company offers a range of membership and wellness packages. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.

Webull offers kinds of Joint Corp stock information, including NASDAQ:JYNT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JYNT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading JYNT stock methods without spending real money on the virtual paper trading platform.